CRISPR/cas9 endonuclease-mediated genome editing was used to create an amino acid substitution at position 129 altering arginine to histidine (R129H; CG to CA) in exon 4. This mutation was identified as a human early-onset ornithine transcarbamylase deficiency associated variant allele. (J:101977)